Posts Tagged ‘Johnson and Johnson mesh’

FDA’s Proposed Tracking System Could Reduce Vaginal Mesh Complications

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh News

The Vaginal Mesh Helpline continues to report on the news that effects women with vaginal mesh complications. The new FDA tracking system comes a little late for the over 300,000 women implanted with vaginal mesh devices and suffering. However, there is hope. This sends a message that our voices have been heard. By filing vaginal mesh lawsuits and standing up for justice you protect yourself and all women from becoming targets of manufacturers who put profits over people.

FDA’s Propose Tracking System Could Reduce Vaginal Mesh Complications
Tracy Ray

The FDA has proposed a new regulation that would require all new medical devices to carry a unique device identifier (UDI). The UDI would be a code of letters and numbers. Such a code would make it much easier to track devices, which in turn would make it much easier to report complications with a particular model or to find out about such problems.

According to the FDA, “A UDI system has the potential to improve the quality of information in medical device adverse event reports, which will help the FDA identify product problems more quickly, better target recalls and improve patient safety.”

For example, if such a tracking system were in place, a doctor who had a patient with stress urinary incontinence (SUI) or pelvic organ prolapse (POP) and wanted to implant a vaginal mesh device could look up the different models by the UDI and immediately see what transvaginal mesh complications, if any, had been reported with each specific model. Likewise, in the event of a recall, a UDI would make the process much more efficient: the company or the FDA would simply announce that the model carrying a particular UDI number was being recalled.

The FDA’s proposal was a response to legislation passed by Congress in 2007 that directed the FDA to develop regulations establishing a unique device identification system for medical devices.
Many women have suffered transvaginal mesh complications

Such a system might enable future patients to avoid problems resulting from transvaginal mesh. Many women have suffered such complications, including pain, infections, mesh erosion, protrusion, vaginal scarring, dyspareunia, and perforation of the bowels, bladder, or blood vessels. Many of these devices were approved under the FDA’s controversial 510(k) approval process, which allows products to be approved without first undergoing clinical trials to prove they are safe.

If the physicians treating these women had been able to easily look up the type of vaginal mesh device they were considering implanting, and immediately see reports of problems associated with the device, they would have been able to weight the risks and make an informed decision about whether to implant that particular device.
Vaginal mesh MDL consolidated lawsuits

Many women who have suffered complications have filed vaginal mesh lawsuits in order to get compensation for their pain, suffering, and reduced quality of life. Most of these lawsuits charge that the manufacturers of these devices did not test them for safety before putting the on the market and failed to warn the public of the devices’ risks. A number of federal lawsuits have been consolidated in a vaginal mesh MDL in West Virginia.

For help call the Vaginal Mesh Helpline and Vaginal Mesh Support Group today, Let us help you find and vaginal mesh lawyer and doctor.

Vaginal Mesh Overview, Vaginal Mesh Lawyers

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh Information

The  Mesh Helpline still hears from women who are having complications and just realized it is from the mesh. Most of these women have seen a lawyer ad on T.V which alerts them to realize they are not alone and that their doctors are giving them the run around. Other women are disenchanted with the T.V ad lawyer they hired or a local lawyer who has sent the case to another lawyer someplace else. There are some basic vaginal mesh guidelines:

Vaginal mesh complications include pain, leakage or incontinence or the bladder or bowel, parch bleeding, infection, pain during sexual intercourse, lower back pain, pain on one side of the body, abdominal pain and difficulty standing for long periods

You are not alone. Close to 400,000 women have vaginal mesh or bladder sling implants

A vaginal mesh comes in many varieties, made by many different manufufacturers. They can be called a sling, a transvaginal mesh, a TVT sling, a bladder sling, a surgical mesh, a vaginal patch and it is still a mesh and part of the Vaginal mesh lawsuts currently underway.

For the men: Sexual intercourse is indeed painful for your wife. She is not lying or making it up. But, with the right doctor there is hope of resuming a normal life. Many men are sueing with their spouse. A California husband just got an award  for $500,000 for loss of intimacy in the relationship.

The mesh can be removed and your body repaired with sutures or another means. A urogynecologist is usually a mesh specialist although a GYN surgeon or urologist can remove the mesh. You must ask the doctors office if the doctor has ever removed a mesh and you must get a straight answer.

Physical therapy will not help the mesh and may be dangerous by pushing it into an organ. This is not a good idea. Estrogen creme will not necessarily help either. You must look into mesh removal.

The vaginal mesh lawsuits are currently underway. It is important to retain a lawyer, and the right lawyer, asap. Statutes of limitations are running out in some states. You will have to go to a doctor to get a statement that you have a mesh problem. If you rely on old medical records it may become harder to prove your case. The best situation is to have a statement in the record that mesh removal or alteration is needed and that you have a mesh issue.

Additional Important Information

Surgical mesh was designed in the 1950s to correct abdominal hernias. The woven material is placed below the skin to patch the abdominal hole and block intestines and other tissues from protruding through the abdominal wall.

Surgical mesh can be made of biological materials or synthetic materials like polypropylene, polytetrafluoroethylene, polyester fibers or stainless steel. The size, shape, thickness and flexibility vary based on the surgeon’s needs. Often, the mesh comes in a prepackaged kit with the necessary tools, to make the procedure easier.

The Food and Drug Administration (FDA) reports that hundreds of thousands of hernia repair surgeries are performed each year — with and without surgical mesh — and patients typically recover quickly. However, the FDA has received reports of adverse reactions to the mesh, adhesions (where the loops of the intestines attach to each other or the mesh), and injury to organs, nerves or blood vessels.

Overall, the treatment of hernias with surgical mesh is considered successful, so doctors wanted to use it in other parts of the body that required additional support. In the 1970s, they began inserting surgical mesh abdominally to treat pelvic organ prolapse (POP). In 1996, the FDA approved the first mesh product for treatment of stress urinary incontinence (SUI). The first mesh product for treatment of prolapse was approved in 2002.

Instead of inserting the mesh through abdominal incisions, however, surgeons have recently embraced the idea of implanting the mesh transvaginally (through the vagina). This choice has been disastrous for thousands of women, who have suffered severe complications such as organ perforation and erosion of the mesh. Even revision surgeries cannot always remove the mesh or correct the internal trauma.
Transvaginal Mesh and Pelvic Organ Prolapse

To treat pelvic organ prolapse, surgical mesh can be implanted at the time of a hysterectomy or as a separate surgery. When surgical mesh is inserted through the vagina, it is referred to as transvaginal mesh.

Pelvic organ prolapse is a condition in which the bladder, top of the vagina, uterus, rectum or bowel has descended from its normal position. The condition is thought to be the result of weakened pelvic muscles, usually from pregnancy and childbirth. Of the 300,000 surgical procedures done to correct prolapse in 2010, 100,000 used mesh and 75,000 of those were completed transvaginally.

When transvaginal mesh is used to repair prolapse, the surgeon uses the woven material to create a hammock-like structure under the drooping organ or organs. Once in place, the mesh is anchored to muscles or ligaments by sutures or other devices. Over time, the patient’s tissues grow and fill in the pores of the mesh to keep it stable. The hammock, in turn, maintains the correct position of the affected organ.
To treat prolapse, transvaginal mesh is most commonly placed in these locations:

    The anterior vaginal wall to correct a bladder prolapse.
    The posterior vaginal wall to correct a rectal prolapse.
    The top of the vagina to correct a uterine prolapse.

The most common and serious of the complications for patients is the erosion, or extrusion, of the mesh into nearby organs. This can lead to bleeding, pain during sexual intercourse and urinary problems. Revision surgeries may not fix the problem. And if the patient’s tissues have already grown through the mesh, removal may be impossible.
Transvaginal Mesh and Stress Urinary Incontinence

Surgical mesh can also be used to create a bladder sling that is positioned under the urethra and bladder neck and anchored on the sides. The bladder sling is designed to treat stress urinary incontinence (SUI), which occurs when the bladder is stressed by an everyday activity, such as sneezing or laughing, and subsequently leaks urine. The sling keeps the urethra and bladder neck closed during normal activities, stopping the leakage. In 2010, nearly 260,000 surgeries were performed to correct SUI. Of those, 80 percent were performed using surgical mesh implanted transvaginally.

When a bladder sling is inserted through the vagina, it is known as transvaginal mesh. Typically, small abdominal incisions are also used.
Among the most popular bladder slings:

    Tension-free vaginal tape (TVT): A polypropylene mesh tape is used under the urethra and is held in place by the patient’s body.
    Transobturator tape (TOT): Less invasive than TVT, because there is no need to use a large needle when inserting it.
    Mini-sling: Eliminates the need for abdominal incisions. A metallic inserter and a vaginal incision are used to place the mesh tape.

As with prolapse surgery, there have been widespread reports of serious complications after bladder sling surgery using transvaginal mesh. Many patients have prolonged difficulty urinating or they incur new symptoms of incontinence, specifically urgency. In addition, they run the risk of the slings eroding into nearby structures, organ perforation, infection at the surgery site and internal bleeding.
Transvaginal Mesh and the FDA

Between 2005 and 2007, the FDA received 1,000 reports of complications and injuries related to transvaginal mesh surgeries, including death. The FDA decided to begin studying the medical device in October 2008. The FDA reported that between 2008 and 2010, there were nearly 2,900 reports of injuries caused by transvaginal mesh.

By July 2011, the federal agency concluded in a public safety update that complications with the use of transvaginal mesh for treatment of prolapse are not rare and that mesh repairs are no more effective than non-mesh repairs for treating prolapse.

The FDA took its concern a step further in January 2012, stating that after studying years of scientific data and recommendations from the September 2011 Obstetrics-Gynecology Devices Panel meeting, it was considering reclassifying transvaginal mesh as a high-risk device. If that happens, mesh devices will be subjected to more rigorous testing, including clinical trials with humans.

In that same update, the FDA requested safety data from all surgical mesh manufacturers and ordered post-market studies from seven manufacturers of single-incision mini-slings for SUI and 33 manufacturers of surgical mesh for prolapse.

If you need help with your vaginal mesh call the Vaginal Mesh Helpline today.

 

 

Avaulta Vaginal Mesh Helpline, Bard Avaulta Vaginal Mesh Lawyer

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh News

Vaginal Mesh Helpline  is provideng vaginal mesh support and Avaulta mesh lawyers for women with complications from the Bard Avaulta Vaginall Mesh. Like all mesh implants  the Bard Avaulta Vaginal Mesh was used for prolapse or unrinary incontinence and is causing all the classic mesh complications.

C.R. Bard's products include:

        Bard Pelvitex
        Bard Pelvisoft
        Bard Pelvilace or Pelvicol
        Bard Utrtex
        Bard Uretex TO
        Bard Uretex TOO2
        Bard Uretex TOO3
 

Complications with Bard Avaulta Vaginal Mesh Include:

  •     Severe physical pain
  •     erosion of the mesh
  •     pain during sexual intercourse
  •     Difficulty voiding
  •     patch bleeding
  •     lower back pain
  •     Reoccurrence of POP or SUI
  •     Severe infection
  •     Urinary  related problems

Bard Avaulta Mesh Lawyers are filing lawsuits for women with complications from the Bard Avaulta Vaginal mesh.
 
If you have complications from a Bard Avaulta vaginal mesh do not wait because the first Bellwether trial is  scheduled in the Bard Avaulta Mesh Implant MDL

The trial is now set to begin on February 5, 2013 in the U.S. District Court for the Southern District of West Virginia.

The purpose of bellwether trials is for both parties to get an idea of how juries will respond to common evidence in representative trials. They can then use this information to negotiate settlements, to plan their strategy for future trials, or to serve as precedents. In January, Judge Goodwin told the attorneys in the Bard MDL to compile a list of possible bellwether cases. Now that a date has been set for the first bellwether trial, a schedule will be established for the discovery process so that the pre-trial proceedings can begin.

You must retain an experienced multi district litigation lawyer immediately. Call the Bard Avaulta vaginal mesh helpline today.

Vaginal Mesh, Urethal Sling Complications

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh News

Use of Vaginal Sling During Surgery Linked to Increased Urethral Sling Complications 1 877 522-2123

Vaginal Mesh Helpline Medical  Update reports on a June 21, 2012 study published in The New England Journal of Medicine, which found that though the insertion of a vaginal sling during surgery decreases the chances of postoperative urinary incontinence, it carries higher risks of urethral sling complications.*

The study analyzed data from 337 participants who underwent surgery to treat pelvic organ prolapse (“POP”) between May 2007 and October 2009. The women were randomly assigned either a vaginal sling or sham incisions. The study found:

        After three months, 23.6 percent of women with the sling had urinary incontinence, compared to 49.4 percent without a vaginal sling.

        After 12 months, 27.3 percent of patients with the sling suffered from urinary incontinence, compared to 43 percent of those without.

        Those implanted with the sling suffered complications. Nearly seven percent of the sling group suffered bladder perforation, versus none in the control group.

        31 percent of women experienced urinary tract infections as a urethral sling complication, versus 18.3 percent in the non-sling group.

        Bleeding complications occurred in 3.1 percent of the sling group; incomplete bladder emptying occurred in 3.7 percent of the sling group. Neither occurred at all in the non-sling group.

Urethral Sling Complications Adds To Concerns About Vaginal Mesh Side Effects

According to an accompany commentary to the study, vaginal mesh slings are different from other types of transvaginal mesh used for POP repair. The slings are small and shaped like straps, approximately 1 cm wide and 10 cm long, while vaginal mesh sheets can span up to 10 cm wide and 20 cm long. In September 2011, the U.S. Food and Drug Administration (“FDA”) convened a panel to evaluate the safety of vaginal mesh implants. Although the agency recommended post market studies for transvaginal mesh, they did not require such studies for midurethral slings. The latest study raises questions about the risks and benefits of vaginal mesh slings. The FDA noted that the vaginal sling provides an “anatomic” benefit, but may not result in better symptomatic results. Since the study was limited to a one year follow up, the long-term consequences of urethral sling complications are still unknown.

Current vaginal mesh lawsuits are increasing. There are numerous vaginal mesh related implants creating severe complications. Many women do not realize that all of these are mesh devices and are part of the huge vaginal mesh lawsuits. The Vaginal mesh helpline currently has a number of pre screened experienced Tort lawyers  for women seeking to file vaginal mesh lawsuits. We cxan also help with doctors in some states.

Vaginal Mesh Lawsuits, Vaginal Mesh Multi District Litigations Proceedings

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh Stories, Vaginal Mesh lawyers

You have been probably reading alot lately about the mesh and the fact that it is a Multi District litigation. In fact that is what this lawsuit is. The vaginal mesh is not a class action lawsuit. Your case is filed locally and then moved to the appropriate MDl  that the manufacturer of your vaginal mesh has been assigned to.

What is a MUlti District litigation ?

Multidistrict litigation is a procedure utilized in the federal court system to transfer to one federal judge all pending civil cases of a similar type filed throughout the United States. The decision whether cases should be transferred is made by a panel of seven federal judges appointed by the Chief Justice of the United States Supreme Court. The Judicial Panel on Multidistrict Litigation meets periodically to review requests that cases be consolidated for pretrial matters pursuant to 28 U.S.C. § 1407

Vaginal mesh MDL'S

In December 2008, all Mentor ObTape lawsuits pending in federal courts were consolidated for MDL in the United States District Court for the Middle District of Georgia, before the Honorable Judge Clay D. Land. In October 2010, 36 lawsuits against Bard (manufacturer of one brand of vaginal mesh) were consolidated for MDL in the Southern District of West Virginia; the number of included cases has since grown to nearly 300. The first vaginal mesh bellwether trial against Bard is scheduled to begin on February 15, 2013. Later, in February 2012, the Judicial Panel on Multidistrict Litigation created three additional MDLs in the Southern District of West Virginia; the defendants are: American Medical Systems; Boston Scientific; and Ethicon. Also in October 2010, Judge Carol E. Higbee of the Superior Court of New Jersey ruled in favor of centralized management for all current and future complaints against manufacturers Johnson &Johnson and Bard (more than 400 such cases have currently been filed). The New Jersey cases are not part of a federal MDL, but are being managed on a state level.

A motion has been filed to create a sixth transvaginal mesh MDL, involving lawsuits over Coloplast pelvic mesh, and a panel of federal judges will meet later this month to consider whether the cases should be consolidated for pretrial proceedings and centralized before the same judge in West Virginia who is presiding over cases involving similar products sold by other manufacturers.

To Summarize the vaginal mesh MDL

There are currently four different MDLs (multidistrict litigations) centralized before Chief District Judge Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia, involving lawsuits over transvaginal mesh products sold by C.R. Bard, American Medical Systems (AMS), Boston Scientific and Ethicon.

A fifth MDL, which was established in 2004 for lawsuits involving Mentor ObTape, is centralized in the U.S. District Court for the Middle District of Georgia. However, many of the Mentor ObTape lawsuits have already settled and the litigation is at a very advanced stage.

Update on Vaginal Mesh Proceedings

Judge Issues Order to Proceed with Discovery in Vaginal Mesh MDL
Emma Gonzalez | July 6th, 2012 |

On June 14, 2012, Chief District Judge Joseph R. Goodwin, who presides over the U.S. District Court for the Western District of West Virginia, issued a pretrial order to proceed with discovery processes in the transvaginal mesh lawsuit MDL. In laymen’s terms, this means that lawyers for the plaintiffs, who allege a variety of vaginal mesh problems, are now able to request evidence, documentation and other paperwork from product manufactures and defendant companies.
Discovery to seek evidence of vaginal mesh problems

True to name, discovery is a legal term for the pretrial process of “discovering” evidence from the opposing party. In this case, Judge Goodwin has authorized vaginal mesh attorneys to seek depositions, interrogatories (fact-gathering questionnaires), and other supporting documentation from vaginal mesh manufacturers and other named defendants. Judge Goodwin’s order is a very important step for the MDL, as it allows counsel to prepare for the first trials.
Judge presides over four transvaginal mesh lawsuit MDL’s

Judge Goodwin will preside over several transvaginal mesh lawsuit MDL’s – those against American Medical Systems, Boston Scientific, C.R. Bard, and Ethicon. While Judge Goodwin has been assigned to the C.R. Bard MDL since 2010, it was not until 2012 that the other three were consolidated and appended to his court docket. The four MDL’s consolidate cases from thousands of women, and currently number 333 against AMS, 182 against Boston Scientific, 411 against C.R. Bard, and 253 against Ethicon. MDL numbers are growing fast, and this rapid rate is not expected to decrease in the near future.
Vaginal mesh attorneys cite range of complications

MDL plaintiffs allege several vaginal mesh problems, among them pelvic organ prolapse and stress urinary incontinence aggravated by vaginal mesh. Additionally, women report chronic infection, bleeding, vaginal scarring, severe discomfort, and pain during intercourse. For some, what was meant to be a solution to their problems results in device erosion – deterioration of the implant – or extrusion, in other words, dislocation of the implant to such a point that it protrudes into the vaginal canal. In the worst of cases, women allege that their defective implants cannot be completely removed, even after multiple surgeries.

It is important to understand that a local lawyer is not necessary for the Vaginal mesh lawsuits. That lawyer will not necessarily be a part of the proceedings but, will most likely be seniding your case to another law firm that is equipped to handle mass torts.

Lead Counsels and the vaginal mesh MDL

On April 13th, Chief Judge Joseph R. Goodwin held a hearing to consider what MDL attorneys will be appointed to serve as lead counsel for the plaintiffs in the consolidated transvaginal mesh litigation.  Attiorneys from around the country comprise the Executive Committee and fifty firms comprise the PSC.

That is why it is extremely important for you to hire an end of the line lawyer so that your casr is not moved from a local law firm to a larger law firm to the MDL lead counsel. Many lead counsels are just end of the libne lawyers and are not taking cases, others are. Your attorney must be familiar with the MDL process. for the Vaginal mesh Helpline dial 1 877 522-2123

What is a vaginal mesh? Get help with Doctors and Vaginal mesh lawyers

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh Stories, Vaginal Mesh lawyers

Vaginal mesh helpline is here to help you understand your vaginal mesh and locate a vaginal mesh lawyer and vaginal mesh doctor

Speak to a female social worker at the vagina Mesh helpline. Helping "women of the Mesh" and reviewing all dangerous drugs and medical devices that harm women like Yaz, Yasmin, Mirena IUD, and all Vaginal mesh, Bladder sling and Prolapse implant devices'What is Vaginal Mesh?

by arthur on March 19, 2012
0
inShare

Vaginal mesh is a medical device made from biological, synthetic (absorbable and non-absorbable), and composite mVaginal Mesh 300×250 2 What is Vaginal Mesh?aterials. Also called a vaginal hammock, vaginal sling or bladder sling, it is placed in the vagina to strengthen the walls and keep pelvic and reproductive organs in their proper positions. Vaginal meshes have been used by physicians since the 1950’s. They were originally designed to treat abdominal hernias and have been modified to also treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). Vaginal mesh surgery became a popular procedure in the 1990’s.

Women may get POP or SUI after childbirth, through hysterectomy (removal of the uterus), or because of aging and menopause. According to the American Urogynecologic Society Foundation (AUGS), about 50 percent of women between 50 to 79 years old suffer from POP, while some 15 million experience SUI. POP starts when the pelvic muscles are stretched and weakened.  Without support from the pelvic muscles, a woman’s reproductive or pelvic organs such as the bladder, urethra, uterus, rectum, or even intestine; have the tendency to move downward and bulge into the vagina. Sometimes, more than one organ moves down from its position.

SUI may also be caused by drinking too many fluids, especially those high in caffeine and/or alcohol content. SUI can also be acquired through the intake of various types of medication, or even due to constipation, pregnancy, or UTI. Changes in lifestyle like diet modification and doing Kegel exercises can treat SUI. However, in cases where it is already affecting one’s daily routine and activities, undergoing a surgical procedure may be necessary.

To treat POP and severe cases of SUI, the vaginal mesh is implanted through the vagina to reinforce the pelvic muscles, anchor the vagina walls, and support the organs. During the surgery, incisions are made in the vagina. The tissues supporting the vagina are then strengthened with stitches. The mesh is then placed under the skin of the vagina. The surgeon may use a generic vaginal mesh, or a pre-cut version that matches the defects that need to be corrected. Either way, the holes of the mesh will allow tissues to grow naturally onto its surface.

Vaginal mesh was introduced to eliminate the need to perform hysterectomy to treat POP. Results of undergoing surgery to get a vaginal mesh were successful for most patients. However, there are also cases when complications occur, including infections, bleeding, pelvic pain, and mesh erosion.

After receiving hundreds of reports from patients who experience complications after their surgery, the US Food and Drug Administration (FDA) issued a warning about the risks associated with the use of vaginal mesh. Some vaginal mesh recipients have filed lawsuits against several vaginal mesh manufacturers. In addition, the FDA found that vaginal meshes placed through the vagina instead of through an incision in the abdomen result in more problems to patients after surgery. The FDA has advised the public to be aware of the risks of said procedure. Women are also encouraged to ask their doctors or surgeons for alternative treatments to POP and SUI

Vaginal mesh Information, Vaginal mesh lawyers

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh News

 A resource for women with Vaginal mesh,  helping women with Mesh complications and assisting with a Urogynecologist and Vaginal Mesh lawyer   We are always  seeking new information for our women of the Vaginal Mesh.

Summary and Overview

FDA Alert – Using surgical mesh for prolapse surgery

FDA safety communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. Vaginal Mesh lawyers are acepting cases for a Multi District litigation

 

 

 

What is a Vaginal Mesh ?

Surgical mesh is a medical device that is generally used to repair weakened or damaged tissue. It is made from porous absorbable or non-absorbable synthetic material or absorbable biologic material. In urogynecologic procedures, surgical mesh is permanently implanted to reinforce the weakened vaginal wall to repair pelvic organ prolapse or to support the urethra to treat urinary incontinence.

More About the vaginal mesh, The Vaginal Mesh  is Used for

Pelvic Organ Prolapse
Pelvic organ prolapse (POP) occurs when the tissues that hold the pelvic organs in place become weak or stretched. Thirty to fifty percent of women may experience POP in their lifetime with 2 percent developing symptoms. When POP happens, the organs bulge (prolapse) into the vagina and sometimes prolapse past the vaginal opening. More than one pelvic organ can prolapse at the same time. Organs that can be involved in POP include the bladder, the uterus, the rectum, the top of the vagina (vaginal apex) after a hysterectomy, and the bowel.

Stress Urinary Incontinence
Stress urinary incontinence (SUI) is a leakage of urine during moments of physical activity, such as coughing, sneezing, laughing, or exercise.

FDA Notices and Warnings

On Oct. 20, 2008, the FDA issued a Public Health Notification and Additional Patient Information on serious complications associated with surgical mesh placed through the vagina (transvaginal placement) to treat POP and SUI.
Based on an updated analysis of adverse events reported to the FDA and complications described in the scientific literature, the FDA identified surgical mesh for transvaginal repair of POP as an area of continuing serious concern.

The FDA is issuing this update to inform you that serious complications associated with surgical mesh for transvaginal repair of POP are not rare. This is a change from what the FDA previously reported on Oct. 20, 2008. Furthermore, it is not clear that transvaginal POP repair with mesh is more effective than traditional non-mesh repair in all patients with POP and it may expose patients to greater risk. This Safety Communication provides updated recommendations for health care providers and patients and updates the FDA’s activities involving surgical mesh for the transvaginal repair of POP.
The FDA continues to evaluate the effects of using surgical mesh to repair SUI and will communicate these findings at a later date.

For detailed information, please see: Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse.

Overview of the Vaginal mesh

In the Oct. 20, 2008 FDA Public Health Notification, the number of adverse events reported to the FDA for surgical mesh devices used to repair POP and SUI for the previous 3-year period (2005 – 2007) was “over 1,000.” Since then, from Jan. 01, 2008 through Dec. 31, 2010, the FDA received 2,874 additional reports of complications associated with surgical mesh devices used to repair POP and SUI, with 1,503 reports associated with POP repairs and 1,371 associated with SUI repairs. Although it is common for adverse event reporting to increase following an FDA safety communication, we are concerned that the number of adverse event reports remains high.
From 2008 – 2010, the most frequent complications reported to the FDA for surgical mesh devices for POP repair include mesh erosion through the vagina (also called exposure, extrusion or protrusion), pain, infection, bleeding, pain during sexual intercourse (dyspareunia), organ perforation, and urinary problems. There were also reports of recurrent prolapse, neuro-muscular problems, vaginal scarring/shrinkage, and emotional problems. Many of these complications require additional intervention, including medical or surgical treatment and hospitalization.

In order to better understand the use of surgical mesh for POP and SUI, the FDA conducted a systematic review of the published scientific literature from 1996 – 2011 to evaluate its safety and effectiveness. The review showed that transvaginal POP repair with mesh does not improve symptomatic results or quality of life over traditional non-mesh repair. The FDA continues to evaluate the literature for SUI surgeries using surgical mesh and will report about that usage at a later date.

In particular, the literature review revealed that:

  • Mesh used in transvaginal POP repair introduces risks not present in traditional non-mesh surgery for POP repair.
  • Mesh placed abdominally for POP repair appears to result in lower rates of mesh complications compared to transvaginal POP surgery with mesh.
  • There is no evidence that transvaginal repair to support the top of the vagina (apical repair) or the back wall of the vagina (posterior repair) with mesh provides any added benefit compared to traditional surgery without mesh.
  • While transvaginal surgical repair to correct weakened tissue between the bladder and vagina (anterior repair) with mesh augmentation may provide an anatomic benefit compared to traditional POP repair without mesh, this anatomic benefit may not result in better symptomatic results.

The FDA’s literature review found that erosion of mesh through the vagina is the most common and consistently reported mesh-related complication from transvaginal POP surgeries using mesh. Mesh erosion can require multiple surgeries to repair and can be debilitating for some women. In some cases, even multiple surgeries will not resolve the complication.

Mesh contraction (shrinkage) is a previously unidentified risk of transvaginal POP repair with mesh that has been reported in the published scientific literature and in adverse event reports to the FDA since the Oct. 20, 2008 FDA Public Health Notification. Reports in the literature associate mesh contraction with vaginal shortening, vaginal tightening and vaginal pain.
Both mesh erosion and mesh contraction may lead to severe pelvic pain, painful sexual intercourse or an inability to engage in sexual intercourse. Also, men may experience irritation and pain to the penis during sexual intercourse when the mesh is exposed in mesh erosion.

The complications associated with the use of surgical mesh for POP repair have not been linked to a single brand of mesh.

Recommendations for Health Care Providers:

As stated in the Oct. 20, 2008 Public Health Notification, the FDA continues to recommend that health care providers should:

  • Obtain specialized training for each mesh placement technique, and be aware of the risks of surgical mesh.
  • Be vigilant for potential adverse events from the mesh, especially erosion and infection.
  • Watch for complications associated with the tools used in transvaginal placement, especially bowel, bladder and blood vessel perforations.
  • Inform patients that implantation of surgical mesh is permanent, and that some complications associated with the implanted mesh may require additional surgery that may or may not correct the complication.
  • Inform patients about the potential for serious complications and their effect on quality of life, including pain during sexual intercourse, scarring, and narrowing of the vaginal wall in POP repair using surgical mesh.
  • Provide patients with a copy of the patient labeling from the surgical mesh manufacturer if available.

In addition, the FDA also recommends that health care providers:

  • Recognize that in most cases, POP can be treated successfully without mesh thus avoiding the risk of mesh-related complications.
  • Choose mesh surgery only after weighing the risks and benefits of surgery with mesh versus all surgical and non-surgical alternatives.
  • Consider these factors before placing surgical mesh:
    • Surgical mesh is a permanent implant that may make future surgical repair more challenging.
    • A mesh procedure may put the patient at risk for requiring additional surgery or for the development of new complications.
    • Removal of mesh due to mesh complications may involve multiple surgeries and significantly impair the patient’s quality of life. Complete removal of mesh may not be possible and may not result in complete resolution of complications, including pain.
    • Mesh placed abdominally for POP repair may result in lower rates of mesh complications compared to transvaginal POP surgery with mesh.
  • Inform the patient about the benefits and risks of non-surgical options, non-mesh surgery, surgical mesh placed abdominally and the likely success of these alternatives compared to transvaginal surgery with mesh.
  • Notify the patient if mesh will be used in her POP surgery and provide the patient with information about the specific product used.
  • Ensure that the patient understands the postoperative risks and complications of mesh surgery as well as limited long-term outcomes data.

Recommendations for Patients:

Before Surgery

  • Be aware of the risks associated with surgical mesh for transvaginal repair of POP. Know that having a mesh surgery may put you at risk for needing additional surgery due to mesh-related complications. In a small number of patients, repeat surgery may not resolve complications.
  • Ask your surgeon about all POP treatment options, including surgical repair with or without mesh and non-surgical options, and understand why your surgeon may be recommending treatment of POP with mesh.

In addition, ask your surgeon these questions before you agree to have surgery in which surgical mesh will be used:

  • Are you planning to use mesh in my surgery?
  • Why do you think I am a good candidate for surgical mesh?
  • Why is surgical mesh being chosen for my repair?
  • What are the alternatives to transvaginal surgical mesh repair for POP, including non-surgical options?
  • What are the pros and cons of using surgical mesh in my particular case? How likely is it that my repair could be successfully performed without using surgical mesh?
  • Will my partner be able to feel the surgical mesh during sexual intercourse? What if the surgical mesh erodes through my vaginal wall?
  • If surgical mesh is to be used, how often have you implanted this particular product? What results have your other patients had with this product?
  • What can I expect to feel after surgery and for how long?
  • Which specific side effects should I report to you after the surgery?
  • What if the mesh surgery doesn’t correct my problem?
  • If I develop a complication, will you treat it or will I be referred to a specialist experienced with surgical mesh complications?
  • If I have a complication related to the surgical mesh, how likely is it that the surgical mesh could be removed and what could be the consequences?
  • If a surgical mesh is to be used, is there patient information that comes with the product, and can I have a copy?

After Surgery

Continue with your annual and other routine check-ups and follow-up care. There is no need to take additional action if you are satisfied with your surgery and are not having complications or symptoms.

Notify your health care provider if you have complications or symptoms, including persistent vaginal bleeding or discharge, pelvic or groin pain or pain with sex, that last after your follow-up appointment.

Let your health care provider know you have surgical mesh, especially if you plan to have another surgery or other medical procedures.
Talk to your health care provider about any questions you may have.
If you had POP surgery, but do not know whether your surgeon used mesh, ask your health care provider at your next scheduled visit.

FDA Activities:

The FDA is working in several areas to assess and improve the safety and effectiveness of urogynecologic mesh products. The FDA will:
Convene the Obstetrics-Gynecology Devices Panel of the Medical Device Advisory Committee, on September 8-9, 2011.The panel will discuss and make recommendations regarding the safety and effectiveness of transvaginal surgical mesh for POP and SUI.

Explore regulatory solutions to answer questions about the safety and effectiveness of urogynecologic mesh products that are now being marketed and those that will be reviewed for marketing in the future.

Continue to monitor adverse events reported to FDA associated with surgical mesh used to repair POP and SUI, as well as assessing any and all data as it becomes available.

Reporting Problems to the FDA:

Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with medical devices. If you suspect a problem with surgical mesh, we encourage you to file a voluntary report through MedWatch, the FDA Safety Information and Adverse Event Reporting program. Health care personnel employed by facilities that are subject to the FDA's user facility reporting requirements should follow the reporting procedures established by their facilities. Device manufacturers must comply with the Medical Device Reporting (MDR) regulations.

To help us learn as much as possible about the adverse events associated with surgical mesh to repair POP and SUI, please include the following information in your reports, if available:
Manufacturer's name
Product name (brand name)
Catalog number
Lot number
Size
Date of implant
Date of explant (if mesh was removed)
Details of the adverse event and medical and/or surgical interventions (if required)
Type of procedure (e.g., anterior or posterior repair, sacral colpopexy, sling procedure for SUI)
Surgical approach: (e.g., vaginal, abdominal, laparoscopic)
Reason for mesh implantation: (e.g., POP of the uterus, bladder, rectum, vaginal apex or bowel, SUI)
Specific postoperative symptoms experienced by the patient with time of onset and follow-up treatment

Additional Contact Information:
If you have questions about this communication, please contact the Division of Small Manufacturers, International and Consumer Assistance (DSMICA) at  800-638-2041 or 301-796-7100.
This document reflects the FDA’s current analysis of available information, in keeping with our commitment to inform the public about ongoing safety reviews of medical devices.

 

 

New Vaginal mesh Guidelines, Vaginal mesh helpline reports

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh News

Transvaginal Mesh Guidelines Created by AHRQ Ignored by FDA
April 27, 2012 Posted by: Barb Stephens

The vaginal mesh helpline and Vaginal mesh lawyers are happy to see the AHRQ   has released guidelines for Mesh Surgery. Women call daily with severe complications from their  vaginal mesh implant. The FDA has offered nothing. Even with the guidelines the horrors of the Vaginal mesh cannot be denied.From listening to women every day it is becoming obvious that the transvaginal mesh is dangerous. Women nationwide have filed lawsuits against several vaginal mesh manufacturers, including Johnson and Johnson and Boston Scientific. Hundreds of these cases have been consolidated in a multidistrict litigation (MDL) in the West Virginia district court.It appears that many more will be added over the next months yet doctors are still putting the mesh in women. Many women call our helpline just months after their surgery with severe discomfort and complications.

Even before the U.S. Food and Drug Administration (FDA) issued warnings against the continued use of transvaginal mesh in patients suffering from pelvic organ prolapse, another governmental agency set its sights on the faulty medical device.The U.S. Agency for Healthcare Research and Quality (AHRQ), which is a branch of the U.S. Department of Health and Human Services, released guidelines for patients considering having the questionable medical device implanted. The guidelines also remind doctors that transvaginal mesh is a new procedure and should be used with caution.
The agency, formerly known as the Agency for Health Care Policy and Research, is the research arm of health and human services. It acts as a regulatory agency for patient safety organizations. In its guidelines for utilizing transvaginal mesh, the agency recommended that doctors, surgeons and nurses be adequately trained in using the device to fix pelvic prolapse before implanting it.

Pelvic prolapse is known to occur in women who are past menopause and childbearing years or who have had a hysterectomy. Because of weakened muscles, the pelvic organs, including the uterus and rectum, can slip into the vagina and cause a host of problems. Agency for Healthcare Research and Quality

Doctors were using transvaginal mesh to fix the problem, but many now realize the all of the transvaginal mesh devices on the market are modeled after one that is faulty in design. This faulty design results in mesh erosion.

Because of this, thousands of women are suffering from injuries that include bleeding, immense pain and punctured internal organs. Many women are forced to have the mesh removed in an attempt to lead a normal, pain-free life.

The FDA’s response to transvaginal mesh has been shoddy at best. In 2008, the agency downplayed patient’s complaints about the mesh, saying problems with it is rare.

Three years later, the FDA did a rare reversal and said that problems with the device are “not rare.” However, nothing has been done to regulate the faulty devices or the manufacturers.

In the years between the two FDA decisions, the AHRQ came out with its guidelines for patients. The agency said patients need to be aware of several issues:

  •     Transvaginal mesh is considered new way to treat pelvic prolapse, thus not proven.
  •     Success rates vary.
  •     There is little information about long-term use.
  •     Serious complications could result from mesh.
  •     Little data exists that transvaginal mesh will actually fix a prolapse problem.
  •     Patients should undergo thorough pre-operative counseling regarding the limited data that exists about the device.

With the mounting medical evidence showing that transvaginal mesh is dangerous, women nationwide have filed court complaints against several mesh manufacturers, including Johnson and Johnson and Boston Scientific. Hundreds of the cases have been consolidated in a multidistrict litigation (MDL) in a West Virginia district court. Contact the Vaginal Mesh helpline to get the facts, get help locating a Doctor for Mesh removal and be connected to an experienced vaginal mesh , mass tort lawyer.

Vaginal Mesh lawyers Filing Lawsuits For Vaginal, Vaginal Mesh Helpline Reports

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh Stories, Vaginal Mesh lawyers

Lawsuits are being Filed by transvaginal mesh lawyers on behalf of women with vaginal mesh complications. Vaginal mesh helpline Keeps women updated on new news regarding the Vaginal Mesh. According to Lisa Spitzer MSW "we must continue to give women hope that they will obtain justice for ruined lives due to these vaginal mesh complications. The pain and suffering is horrific"

New Lawsuit Filed on Trasvaginal Mesh Serious Complications: the Threat of Severe Adverse Events from Transvaginal Mesh Remains
According to court documents, on April 10th, 2012 an Illinois woman, a Vaginal meshh lawyer , filed a lawsuit in West Virginia Southern District Court (case no. 2:2012cv01025) alleging she suffered a multitude of medical problems as a result of a transvaginal mesh surgery to treat a pelvic organ prolapse (POP). Plaintiff was surgically implanted with the Pelvitex polypropylene vaginal mesh system and she is suing Bard Healthcare, a division of C.R. Bard, Inc., et al for nearly $10 million in damages. Transvaginal surgical mesh is used to treat pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI). Several lawsuits against C.R. Bard were consolidated in October 2010 as part of an MDL (No.2187) in the US District Court for the Southern District of West Virginia. Vaginal Mesh helpline can provide helpful, proven advice and simple solutions including how to get in contact a vaginal mesh lawyer so anyone can easily and inexpensively deal with cases of Transvaginal Mesh horrors.

The vaginal mesh Helpline Speaks to women daily regarding their mesh complications and hears many stories. Many are very similiar, inability to have sexual intercourse, severe pain, mesh erosion thru the vaginal wall, spot bleeding, infections, pain on one side of the body,

lower back pain, and Doctors being unsympathetic to the problems they are having. We speak to women from Florida to California and as far north as Canada. "The stories are horrific and women are truly suffering. We are here to help" Says spitzer. 

Has A Lawyer rejected Your Vaginal Mesh Case ? Get a Second Opinion

Written by Vaginal Mesh Helpline on . Posted in Vaginal Mesh Information

At the Vaginal Mesh Helpline we have been contacted by many women whose vaginal mesh case has been rejected by a law firm for many different reasons. Many are inexperienced local lawyers while  others have been rejected for a variety of other reasons. The key factors appear to be lack of confirmation from a physician that the mesh is casuing a problem and that either revision surgery or removeal is needed. Well ladies ,you know when you have symptoms. However, many doctors are not willing to say that the mesh is causing a problem or women do not have funds to go to a doctor. Call the vaginal mesh helpline to be connected to a law fim  and get a second opinion. Do not give up hope . You must seek justice.

FDA Adverse reporting Guidelines
Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with medical devices. If you suspect a problem with surgical mesh, we encourage you to file a voluntary report through MedWatch, the FDA Safety Information and Adverse Event Reporting program. Health care personnel employed by facilities that are subject to the FDA's user facility reporting requirements should follow the reporting procedures established by their facilities. Device manufacturers must comply with the Medical Device Reporting (MDR) regulations.

To help us learn as much as possible about the adverse events associated with surgical mesh to repair POP and SUI, please include the following information in your reports, if available:

Documenting this type of information will be extremely helpful when you contact a lawyer as well. The FDA guidlines are an excellent record keeping formate to follow.

  •     Manufacturer's name
  •     Product name (brand name)
  •     Catalog number
  •     Lot number
  •     Size
  •                               Your Lawyer Will Want to Know
  •     Date of implant
  •     Date of explant (if mesh was removed)  (Important)
  •     Details of the adverse event and medical and/or surgical interventions ( Important )
  •  
  •     Type of procedure (e.g., anterior or posterior repair, sacral colpopexy, sling procedure for SUI)
  •     Surgical approach: (e.g., vaginal, abdominal, laparoscopic)
  •     Reason for mesh implantation: (e.g., POP of the uterus, bladder, rectum, vaginal apex or bowel, SUI)
  •     Specific postoperative symptoms experienced by the patient with time of onset and follow-up treatment

Vaginal mesh failure symptoms

Complications of the Vaginal Mesh include:

  • Failure of the Procedure
  • Pain (Vagina, leg, pelvic, adbominal)
  • rejection of the graft material
  • chronic continuous relentless infections
  • the need for constant antibiotics
  • patch bleeding
  • lower back pain
  • pain on one side of the body
  • painful sexual intercourse
  • partner feeling the mesh
  • constant bleeding or spotting
  • Recurrent urinary tract infection
  • Extrusion of the mesh into the vagina causing pain, discharge, bleeding
  • Erosion of the mesh into bowel, bladder, urethra, or rectum

For medical Support

Contact a local University Hospital Dept of Urogynecology

or the American Association of Urogynecology

or see the states and resource pages on vaginalmeshhelpline.com